PAD Profile : Iloprost - Raynaud's Phenomenon

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Iloprost - Raynaud's Phenomenon

PAD Profile : Iloprost - Raynaud's Phenomenon

Keywords :

Raynaud's disease, Raynaud's syndrome

Brand Names Include :

Ventavis

Traffic Light Status

Status 1 of 1.

Status :

Red

Formulations :

Intravenous infusion

Trust Alignment :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

BNF NICE SPC

Comments :

No comments returned.

Documents :

Guidelines

No guidelines returned.

Other Drugs

Nifedipine

Other Indications

No indications returned.

Additional Documents

No additional documents returned.

Committee Recommendations

Date

Committee Name

Narrative

01 April 2013

Not Set

Responsible commissioners are CCGs. Iloprost for this indication is considered a RED drug and treatment should be initiated and monitored by specialists in hospitals. There should be no prescribing in primary care

Associated BNF Codes

02. Cardiovascular System

02.05.01. Vasodilator antihypertensive drugs